Medication info
Telmisartan Plus Tablet 80/12.5 mg (Telmisartan, Hydrochlorothiazide)

Telmisartan Plus Tablet 80/12.5 mg (Telmisartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hallym Pharmaceutical Co., Ltd.
Appearance
White or nearly white, convex, round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201900128 · Approved 2019.01.11 · Insurance code 645305990

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dose adjustment is necessary.
Child dose
Under 18 years of age: The safety and efficacy of this medicine have not been established.

Ingredients

Manufacturer
Hallym Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension where blood pressure control is difficult with telmisartan alone. It effectively lowers blood pressure and aids in the management of hypertension. This contributes to the prevention of cardiovascular complications. Administer appropriately according to the patient's blood pressure condition while considering safety and efficacy. It is used for the improvement of hypertension.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dose adjustment is necessary.

Child dose

Under 18 years of age: The safety and efficacy of this medicine have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be stopped immediately upon confirmation of pregnancy. Patients with allergies to the components of this medication or those with specific liver or kidney diseases should not use it. Elderly patients, those with high potassium levels, and patients with impaired liver function should take this medication with caution. The hydrochlorothiazide component may cause increased sensitivity to sunlight, so precautions against UV exposure are necessary, and regular skin examinations are required due to the increased risk of skin cancer. Symptoms such as dizziness, hypotension, and electrolyte imbalance may occur while taking this medication, and if any symptoms arise, immediate consultation with healthcare personnel is necessary. Interactions may occur when taken with other antihypertensive medications or specific drugs, so it is essential to inform healthcare personnel of any ongoing medications. Caution is required when driving or operating machinery, as symptoms of dizziness or drowsiness may occur. Pregnant or breastfeeding individuals should not take this medication, and those planning to become pregnant should be switched to another safer medication. Overdose may lead to hypotension, electrolyte abnormalities, and dehydration, hence prescribed dosages should be strictly followed. Safety has not been established for children, so this medication should not be administered to them. This medication should be kept out of the reach of children and should not be transferred to another container.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is important to maintain a room temperature between 1 and 30 degrees Celsius during storage to preserve the effectiveness of the medication over time.

Appearance and packaging

Appearance

White or nearly white, convex, round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.